SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Questcor Pharmaceuticals, Inc. (Headquarters) Release: New Research Suggests That Acthar Reduces Proteinuria in Idiopathic Membranous Nephropathy In Part Through Suppression of Anti-PLA2R Antibodies